Biomarin Pharmaceutical Inc (BMRN)
92.04
+2.55
(+2.85%)
USD |
NASDAQ |
Apr 23, 16:00
92.06
+0.02
(+0.02%)
After-Hours: 20:00
Biomarin Pharmaceutical Cash from Investing (TTM): -111.24M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -111.24M |
| September 30, 2023 | -100.99M |
| June 30, 2023 | -78.59M |
| March 31, 2023 | -137.82M |
| December 31, 2022 | -20.03M |
| September 30, 2022 | -20.74M |
| June 30, 2022 | -117.18M |
| March 31, 2022 | -207.74M |
| December 31, 2021 | -366.31M |
| September 30, 2021 | -299.86M |
| June 30, 2021 | -73.32M |
| March 31, 2021 | -201.81M |
| December 31, 2020 | -53.62M |
| September 30, 2020 | -113.54M |
| June 30, 2020 | -171.56M |
| March 31, 2020 | 96.86M |
| December 31, 2019 | -31.03M |
| September 30, 2019 | -53.09M |
| June 30, 2019 | 300.56M |
| March 31, 2019 | 285.61M |
| December 31, 2018 | 264.35M |
| September 30, 2018 | 474.86M |
| June 30, 2018 | -357.70M |
| March 31, 2018 | -402.24M |
| December 31, 2017 | -305.46M |
| Date | Value |
|---|---|
| September 30, 2017 | -754.65M |
| June 30, 2017 | -651.36M |
| March 31, 2017 | -536.00M |
| December 31, 2016 | -484.05M |
| September 30, 2016 | -94.85M |
| June 30, 2016 | 169.01M |
| March 31, 2016 | -351.73M |
| December 31, 2015 | -1.180B |
| September 30, 2015 | -796.46M |
| June 30, 2015 | -920.86M |
| March 31, 2015 | -516.02M |
| December 31, 2014 | 196.33M |
| September 30, 2014 | -572.84M |
| June 30, 2014 | -382.05M |
| March 31, 2014 | -329.43M |
| December 31, 2013 | -298.85M |
| September 30, 2013 | -44.72M |
| June 30, 2013 | -68.98M |
| March 31, 2013 | -233.62M |
| December 31, 2012 | -195.64M |
| September 30, 2012 | -178.21M |
| June 30, 2012 | -215.58M |
| March 31, 2012 | -62.49M |
| December 31, 2011 | -89.56M |
| September 30, 2011 | -68.26M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-366.31M
Minimum
Dec 2021
300.56M
Maximum
Jun 2019
-92.69M
Average
-100.99M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| Eli Lilly and Co | -7.153B |
| Merck & Co Inc | -14.08B |
| Pfizer Inc | -32.28B |
| Bristol-Myers Squibb Co | -2.295B |
| Moderna Inc | 4.206B |